OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
EPSM$1.4255

Epsium Enterprise Ltd

Food Retail & DistributionVerified

Epsium Enterprise Ltd maintains a strong liquidity position, with cash and equivalents amounting to $1,978,730, representing 17.2% of total equity. The company's enterprise value to revenue ratio of 3.34 suggests a relatively low valuation compared to revenue, and its debt-to-equity ratio of 0.0 indicates no leverage. This capital structure supports operational flexibility and reduces financial risk. Profitability metrics show mixed performance. The company reported negative operating cash flow of $2,379,180, which may signal operational inefficiencies or high working capital requirements. However, the absence of debt and the high cash reserves mitigate some of the risks associated with negative cash flow. The company's return on invested capital (ROIC) and other profitability metrics are not disclosed, but the lack of leverage suggests a conservative capital allocation strategy. Geographically and segment-wise, Epsium Enterprise Ltd's revenue concentration is not disclosed in the available data. The company operates in the Food & Drug Retailing industry, which is typically characterized by stable demand and high customer retention. However, without segment-specific revenue breakdowns, it is difficult to assess the company's exposure to different product lines or geographic regions. The company's growth trajectory is not clearly defined in the available data. No specific revenue growth rates or future projections are provided. The capital expenditure of $4,160 is minimal, suggesting limited investment in new assets or expansion. This could indicate a mature business with limited growth opportunities or a focus on maintaining existing operations. Risk factors for Epsium Enterprise Ltd are minimal in the short term. The company has no immediate liquidity or dilution flags, and its low debt-to-equity ratio reduces financial risk. However, the negative operating cash flow is a concern that may require further investigation. The company has not issued additional shares recently, and there is no indication of near-term dilution pressure. Recent events and filings do not show any material changes in the company's operations or financial position. The company's financial statements and disclosures are consistent with a stable but low-growth business model. No significant regulatory or geopolitical risks are highlighted in the available data.

30-day price · EPSM(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyEpsium Enterprise Ltd
TickerEPSM.O
SectorConsumer Non-Cyclicals
BusinessFood & Drug Retailing
Industry groupFood & Drug Retailing
IndustryFood Retail & Distribution
AI analysis

Business. Epsium Enterprise Ltd operates in the Food Retail & Distribution industry, primarily generating revenue through the sale of food and drug products to consumers.

Classification. Epsium Enterprise Ltd is classified under the Consumer Non-Cyclicals economic sector, Food & Drug Retailing business sector, and Food Retail & Distribution industry, with a confidence level of 0.92.

Epsium Enterprise Ltd maintains a strong liquidity position, with cash and equivalents amounting to $1,978,730, representing 17.2% of total equity. The company's enterprise value to revenue ratio of 3.34 suggests a relatively low valuation compared to revenue, and its debt-to-equity ratio of 0.0 indicates no leverage. This capital structure supports operational flexibility and reduces financial risk. Profitability metrics show mixed performance. The company reported negative operating cash flow of $2,379,180, which may signal operational inefficiencies or high working capital requirements. However, the absence of debt and the high cash reserves mitigate some of the risks associated with negative cash flow. The company's return on invested capital (ROIC) and other profitability metrics are not disclosed, but the lack of leverage suggests a conservative capital allocation strategy. Geographically and segment-wise, Epsium Enterprise Ltd's revenue concentration is not disclosed in the available data. The company operates in the Food & Drug Retailing industry, which is typically characterized by stable demand and high customer retention. However, without segment-specific revenue breakdowns, it is difficult to assess the company's exposure to different product lines or geographic regions. The company's growth trajectory is not clearly defined in the available data. No specific revenue growth rates or future projections are provided. The capital expenditure of $4,160 is minimal, suggesting limited investment in new assets or expansion. This could indicate a mature business with limited growth opportunities or a focus on maintaining existing operations. Risk factors for Epsium Enterprise Ltd are minimal in the short term. The company has no immediate liquidity or dilution flags, and its low debt-to-equity ratio reduces financial risk. However, the negative operating cash flow is a concern that may require further investigation. The company has not issued additional shares recently, and there is no indication of near-term dilution pressure. Recent events and filings do not show any material changes in the company's operations or financial position. The company's financial statements and disclosures are consistent with a stable but low-growth business model. No significant regulatory or geopolitical risks are highlighted in the available data.
Key takeaways
  • Epsium Enterprise Ltd has a strong liquidity position with no leverage, reducing financial risk.
  • The company's negative operating cash flow is a red flag that may require further analysis.
  • The low enterprise value to revenue ratio suggests the company is undervalued relative to its revenue.
  • There are no immediate liquidity or dilution risks, and the company has not issued additional shares recently.
  • The company's growth trajectory is unclear, and there is limited investment in new assets or expansion.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyUSD
Revenue$5.1M
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow-$2.4M
CapEx-$4.2k
Free cash flow
Total assets
Total liabilities$1.8M
Total equity$11.5M
Cash & equivalents$2.0M
Long-term debt
Valuation
Market price$1.42
Market cap$19.1M
Enterprise value$17.1M
P/E
Reported non-GAAP P/E
EV/Revenue3.3
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash$2.0M
Current ratio
Debt/Equity0.0
ROA
ROE
Cash conversion
CapEx/Revenue-0.1%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskLow
  • No immediate filing-based liquidity or dilution flags were detected.
Industry benchmarks
Activity: Food & Drug Retailing · cohort 184 companies
MetricEPSMActivity
Op margin3.1% medp25 1.2% · p75 6.8%
Net margin2.0% medp25 0.7% · p75 4.1%
Gross margin26.1% medp25 17.2% · p75 32.0%
CapEx / revenue-0.1%-2.5% medp25 -4.6% · p75 -1.4%top quartile
Debt / equity0.0%56.0% medp25 16.8% · p75 121.1%bottom quartile
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 22:14 UTC#c9c493f4
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 21:25 UTCJob: fde5d644